News
-
-
-
COMMUNIQUÉ DE PRESSE
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog
MIRA Pharmaceuticals announces positive Phase 1 results for oral candidate Ketamir-2, showing safe, well-tolerated, predictable absorption, and no CNS side effects -
-
-
COMMUNIQUÉ DE PRESSE
Amarc Announces Important Drill Intersection Southeast of the 2024 Aurora Copper-Gold Discovery Drill Holes at Joy
Amarc Resources Ltd. announces partial hole assay results revealing large-scale exploration potential at JOY District, with Cu-Au-Ag mineralization outside strong magnetic highs -
COMMUNIQUÉ DE PRESSE
Informations privilégiées / Communiqué sur comptes, résultats
-
-
-